DIA, founded as the Drug Information Association, has named Joy Whitlow as Chief Financial Officer. As CFO, Whitlow will be tasked with guiding the business performance and strategic risk processes of the 55-year old organization, which provides the largest neutral, multidisciplinary forum for life science professionals to engage with key stakeholders and each other, ultimately resulting in faster, better patient outcomes worldwide.

Prior to joining DIA, Whitlow served as CFO of the American Association of Motor Vehicle Administrators (AAMVA), where she oversaw all financial operations with federal agencies, financial partners, and member jurisdictions. Before AAMVA, Whitlow spent eight years as CFO at the National Association of Broadcasters (NAB), and prior to that, served in various finance roles in public radio and television, including at WGBH in Boston, the largest public broadcasting station in the country. She is a licensed CPA, who holds a Master’s Degree from The Johns Hopkins University and an undergraduate degree from Brown University.

“With significant expertise in both strategic and operational finance, Joy’s knowledge in different verticals and her global view will allow DIA to not only continue its mission, but expand its presence upon the world stage,” said Barbara Lopez Kunz, MS, Global Chief Executive, DIA. “An increasingly challenging nonprofit and geo-political environment, coupled with complex regulatory framework and the pressure to bring innovative products to market, means that DIA must continue to provide strong, sure groundwork and learning opportunities for the growth of our members and for the impact we collectively will have on patients. I am looking forward to working with Joy in preparation for the possibilities of tomorrow.”

“I’m committed to the promise of DIA and excited about leading the organization to increasing operational performance,” said Whitlow. “We want to adapt, remain nimble, and continue to be the body of choice that trains, educates, and brings people together – collaboratively unlocking the best for patients worldwide.”